BBR Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-885
Closed -$211K 234
2022
Q1
$211K Sell
885
-29
-3% -$6.81K 0.02% 219
2021
Q4
$209K Buy
+914
New +$201K 0.02% 189
2021
Q1
Sell
-1,468
Closed -$267K 209
2020
Q4
$267K Buy
1,468
+27
+2% +$4.59K 0.02% 156
2020
Q3
$241K Buy
+1,441
New +$243K 0.02% 159
2020
Q1
Sell
-1,010
Closed -$203K 170
2019
Q4
$203K Buy
1,010
+11
+1% +$2.26K 0.02% 187
2019
Q3
$211K Buy
+999
New +$209K 0.03% 122

Other funds holding CME

BBR Partners's CME Position: Q2 2022 in Review

BBR Partners sold out of CME Group (CME) in Q2 2022, closing a stake of 885 shares — an estimated $211K sold.

BBR Partners first reported a position in CME in Q3 2019 and held it in 6 quarters. The position peaked at $267K in Q4 2020. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • BBR Partners reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
  • BBR Partners sold 885 CME Group shares in Q2 2022, an estimated $211K.
  • BBR Partners first reported a position in CME Group in Q3 2019 and held it in 6 quarters.
  • BBR Partners's CME Group position peaked at $267K in Q4 2020.
  • 1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on BBR Partners's 13F filing for Q2 2022, filed 12 Aug 2022.